Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Wearable Consumer-Grade Health Monitors May Work, Yet Diagnostic FDA Approved Devices Still Gold Standard for Heart Arrhythmia Diagnosis

Sales of smart watches and fitness trackers are booming, but these consumer technologies aren't meant to diagnose, prevent, or manage any health condition. Stuart Long, CEO of InfoBionic, explains why clinicians rely on standard medical devices, such as an FDA approved diagnostic wearable ECG, for the most accurate information possible.


News provided by

InfoBionic

Aug 25, 2021, 09:05 ET

Share this article

Share toX

Share this article

Share toX

Many of these popular market products have indeed received FDA approval as remote health monitors. However, the real question is does the information save your life?
Many of these popular market products have indeed received FDA approval as remote health monitors. However, the real question is does the information save your life?

WALTHAM, Mass., Aug. 25, 2021 /PRNewswire-PRWeb/ -- According to the Pew Research Center, one-in-five Americans used a smart watch or fitness tracker at the beginning of 2020.(1) These wearable technologies provide vital-sign data, and many now offer electrocardiogram (ECG) functionality to better monitor heart health. But these products aren't a substitute for devices specifically built for diagnostic cardiac monitoring, like standard 3-lead 2 channel ECGs. Stuart Long, CEO of InfoBionic, provider of mobile cardiac monitoring systems, says, "These devices can give consumers all sorts of information, but they cannot substitute more specialized technology for diagnostic purposes. Specifically built technology provides continuous monitoring of many cardiac conditions. It uses collected data to verify events and correlate symptoms to abnormal heart rhythms. This gives clinicians more information to make an accurate and timely diagnosis."

Atrial fibrillation (AFib) is a common heart rhythm disorder resulting from irregular electrical activity within the heart muscle.(2) It's estimated that about 12.1 million Americans will receive an AFib diagnosis by the year 2030.(3) This chronic health condition causes the upper two chambers of the heart, the atria, to beat irregularly, which interrupts normal blood flow throughout the heart and body.

These devices can give consumers all sorts of information, but they cannot substitute more specialized technology for diagnostic purposes. Specifically built technology provides continuous monitoring of many cardiac conditions.

Post this

Many cardiologists monitor patients with AFib using ECG, since this technology immediately detects changes to the electrical activity in the heart leading to unusual heart rhythms. Continuous monitoring is achieved with FDA-approved medical devices dedicated to remote patient monitoring (RPM). These devices are intended for use in the prevention, diagnosis, or treatment of diseases like AFib.(4)

Many of these popular market products have indeed received FDA approval as remote health monitors. However, the real question is does the information save your life? Long explains that the FDA has 3 categories(5) when it comes to monitoring.

Class 1
The US FDA defines Class I devices as devices which are "not intended for use in supporting or sustaining life or of substantial importance in preventing impairment to human health, and they may not present a potential unreasonable risk of illness or injury."

Class 2
Class II medical devices are more complicated than Class I devices and present a higher category of risk because they are more likely to come into sustained contact with a patient. This can include devices which come into contact with a patient's cardiovascular system or internal organs, and diagnostic tools.

Class 3
The FDA defines Class III devices as products which "usually sustain or support life, are implanted or present a potential unreasonable risk of illness or injury." Just 10 percent of the devices regulated by the US FDA fall into Class III. This classification is generally extended to permanent implants, smart medical devices, and life support systems.

In its most basic description and related specific to cardiac monitoring, Level 1 is approval for screening, not for diagnosis; smart watches are an example. Level 2 is approved for diagnosis, but they cannot be relied upon for emergency care. This is the case for medical devices such as InfoBionic's MoMe® Kardia monitor. Level 3 is the one in the hospital that is always sending real-time data being continually monitored live by a medical professional who can take immediate life-saving action should the monitor alert there's a health emergency.

But wearable health devices are still useful. Certain algorithms can help to determine a person's risk of heart disease or stroke based on device reading. This in turn helps motivate people to take specific steps to improve their health. This means consumers engage more, educating and enabling themselves to take greater control of their own health.

RPM Devices Offer Specific Benefits for Providers, Patients
As more healthcare practitioners turn to RPM devices to keep tabs on health consumers, a growing number of benefits are already being realized. These include:(6)

  • Ability to collect various types of data using one device
  • Better management of chronic health conditions
  • Ease of access to patient data
  • Increased efficiency in practice
  • Lower cost

Consumers, who are becoming more comfortable with RPM technology, also benefit from:(5)

  • Better clinical outcomes
  • Continuous monitoring of potentially dangerous health conditions
  • Empowerment to take better care of their health
  • Immediate transfer of clinical data to their provider
  • Lower risk of hospitalization and complications
  • Lower healthcare costs
  • Not having to enter their own data into any computer or system

It's not to say that smart watches and fitness trackers have no place in healthcare. Instead, we should realize that these tools can be used in addition to dedicated RPM devices. Remote monitors, smart watches, and trackers can even be used together to present a more complete picture of a person's health.

"The difference between a smart watch and a diagnostic RPM is that the medical device is prescribed by a doctor and a qualified clinician is at the other end, who can detect when there's a problem. The doctor can call the patient and advise him or her to as to next steps in their care. It's important to use the right tool for the right job, especially when it comes to cardiac care," says Long.

About InfoBionic:
InfoBionic is a digital health company transforming the efficiency and economics of ambulatory remote patient monitoring processes by optimizing clinical and real-world utility for the users that need it most – physicians and their patients. The Massachusetts-based team of seasoned entrepreneurs have had successful careers in healthcare, IT, medical devices and mobile technology, and bring specific expertise in remote monitoring and cardiology. They have seen first-hand the complexities of traditional cardiac arrhythmia detection and monitoring processes and designed the transformative MoMe® Kardia platform to remove the roadblocks hindering faster, more effective diagnosis and decision-making. Frost & Sullivan bestowed the 2019 North American Remote Cardiac Monitoring Technology Leadership Award upon InfoBionic.

Sources
1.    Vogels, Emily A. "About One-in-Five Americans Use a Smart Watch or Fitness Tracker." Pew Research Center, Pew Research Center, 14 Aug. 2020, pewresearch.org/fact-tank/2020/01/09/about-one-in-five-americans-use-a-smart-watch-or-fitness-tracker.
2.    "Atrial Fibrillation." Mayo Clinic, Mayo Foundation for Medical Education and Research, 20 June 2019, mayoclinic.org/diseases-conditions/atrial-fibrillation/symptoms-causes/syc-20350624.
3.    "Atrial Fibrillation." Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, 8 Sept. 2020, cdc.gov/heartdisease/atrial_fibrillation.htm.
4.    "How FDA Approval Affects YOUR Wearables, and How It's Going to Change." Wareable, 17 Jan. 2018, wareable.com/wearable-tech/fda-wearables-state-of-play-239.
5.    Fenton, Robert; "What are the Differences in the FDA Medical Device Classes?"; 29 July 2021; Qualio; qualio.com/blog/fda-medical-device-classes-differences
6.    Scott , Jordan. "The Benefits of REMOTE Patient Monitoring Are Wide Ranging." Technology Solutions That Drive Healthcare, 24 Sept. 2020, healthtechmagazine.net/article/2021/06/benefits-remote-patient-monitoring-are-wide-ranging-perfcon.

Media Contact

Karla Jo Helms, JOTO PR Disruptors(TM), 727-777-4621, [email protected]

Daniel Mutter, JOTO PR Disruptors(TM), 727-777-4621, [email protected]

Twitter

SOURCE InfoBionic

Related Links

http://infobionic.com

Modal title

Stuart Long
Stuart Long
Stuart Long

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.